Preferential Misincorporation of Purine Nucleotides by Human DNA Polymerase η Opposite Benzo[a]pyrene 7,8-Diol 9,10-Epoxide Deoxyguanosine Adducts*

Human DNA polymerase η was used to copy four stereoisomeric deoxyguanosine (dG) adducts derived from benzo[a]pyrene 7,8-diol 9,10-epoxide (diastereomer with the 7-hydroxyl group and epoxide oxygen trans (BaP DE-2)). The adducts, formed by either cis or trans epoxide ring opening of each enantiomer of BaP DE-2 by N 2 of dG, were placed at the fourth nucleotide from the 5′-end in two 16-mer sequence contexts, 5′∼CG*A∼ and 5′∼GG*T. polη was remarkably error prone at all four diol epoxide adducts, preferring to misincorporate G and A at frequencies 3- to more than 50-fold greater than the frequencies for T or the correct C, although the highest rates were 60-fold below the rate of incorporation of C opposite a non-adducted G. Antito syn rotation of the adducted base, consistent with previous NMR data for a BaP DE-2 dG adduct placed just beyond a primer terminus, provides a rationale for preferring purine misincorporation. Extension of purine misincorporations occurred preferentially, but extension beyond the adduct site was weak withV max/K m values generally 10-fold less than for misincorporation. Mostly A was incorporated opposite (+)-BaP DE-2 dG adducts, which correlates with published observations that G → T is the most common type of mutation that (+)-BaP DE-2 induces in mammalian cells.

[1]  Y. Fujii‐Kuriyama,et al.  Expression of human and mouse genes encoding polκ: testis‐specific developmental regulation and AhR‐dependent inducible transcription , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[2]  R. Woodgate,et al.  Crystal Structure of a Y-Family DNA Polymerase in Action A Mechanism for Error-Prone and Lesion-Bypass Replication , 2001, Cell.

[3]  C. Kisker,et al.  Error-Prone DNA Polymerases Novel Structures and the Benefits of Infidelity , 2001, Cell.

[4]  T. Steitz,et al.  Crystal structure of a DinB lesion bypass DNA polymerase catalytic fragment reveals a classic polymerase catalytic domain. , 2001, Molecular cell.

[5]  Robert E. Johnson,et al.  Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis. , 2001, Molecular cell.

[6]  Z. Livneh DNA Damage Control by Novel DNA Polymerases: Translesion Replication and Mutagenesis* , 2001, The Journal of Biological Chemistry.

[7]  T. Kunkel,et al.  The Y-family of DNA polymerases. , 2001, Molecular cell.

[8]  D. Jerina,et al.  O(6)-allyl protected deoxyguanosine adducts of polycyclic aromatic hydrocarbons as building blocks for the synthesis of oligonucleotides. , 2001, Chemical research in toxicology.

[9]  S. Broyde,et al.  Evading the proofreading machinery of a replicative DNA polymerase: induction of a mutation by an environmental carcinogen. , 2001, Journal of molecular biology.

[10]  Robert E. Johnson,et al.  Role of DNA Polymerase η in the Bypass of a (6-4) TT Photoproduct , 2001, Molecular and Cellular Biology.

[11]  A. Grollman,et al.  Influence of flanking sequence context on the mutagenicity of acetylaminofluorene-derived DNA adducts in mammalian cells. , 2001, Biochemistry.

[12]  Yanbin Zhang,et al.  Error-prone lesion bypass by human DNA polymerase eta. , 2000, Nucleic acids research.

[13]  Fenghua Yuan,et al.  Error-free and error-prone lesion bypass by human DNA polymerase κ in vitro , 2000 .

[14]  M. Goodman,et al.  The expanding polymerase universe , 2000, Nature Reviews Molecular Cell Biology.

[15]  Robert E. Johnson,et al.  Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase η , 2000, Nature Genetics.

[16]  Satya Prakash,et al.  Eukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions , 2000, Nature.

[17]  F. Hanaoka,et al.  Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.

[18]  Chikahide Masutani,et al.  Low fidelity DNA synthesis by human DNA polymerase-η , 2000, Nature.

[19]  F. Hanaoka,et al.  Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. , 2000, Biochemistry.

[20]  Satya Prakash,et al.  Fidelity of Human DNA Polymerase η* , 2000, The Journal of Biological Chemistry.

[21]  H. Nasheuer,et al.  Eukaryotic DNA polymerases, a growing family. , 2000, Trends in biochemical sciences.

[22]  R. Fuchs,et al.  Lesions in DNA: hurdles for polymerases. , 2000, Trends in biochemical sciences.

[23]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[24]  T. Lindahl,et al.  Quality control by DNA repair. , 1999, Science.

[25]  D. Jerina,et al.  Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S, 10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells. , 1999, Carcinogenesis.

[26]  Robert E. Johnson,et al.  Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Jerina,et al.  Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene. , 1999, Carcinogenesis.

[28]  R. Woodgate A plethora of lesion-replicating DNA polymerases. , 1999, Genes & development.

[29]  E. Friedberg,et al.  Novel DNA Polymerases Offer Clues to the Molecular Basis of Mutagenesis , 1999, Cell.

[30]  Robert E. Johnson,et al.  hRAD30 mutations in the variant form of xeroderma pigmentosum. , 1999, Science.

[31]  R. Wood DNA repair: Variants on a theme , 1999, Nature.

[32]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[33]  F. Hanaoka,et al.  Xeroderma pigmentosum variant (XP‐V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity , 1999, The EMBO journal.

[34]  Samuel H. Wilson,et al.  “Action-at-a-Distance” Mutagenesis , 1999, The Journal of Biological Chemistry.

[35]  Robert E. Johnson,et al.  Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. , 1999, Science.

[36]  D. Jerina,et al.  Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies. , 1998, Biochemistry.

[37]  D. Patel,et al.  Structural alignment of the (+)-trans-anti-benzo[a]pyrene-dG adduct positioned opposite dC at a DNA template-primer junction. , 1997, Biochemistry.

[38]  W. Kaufmann,et al.  Replication Fork Bypass of a Pyrimidine Dimer Blocking Leading Strand DNA Synthesis* , 1997, The Journal of Biological Chemistry.

[39]  D. Patel,et al.  Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove. , 1996, Biochemistry.

[40]  D. Patel,et al.  Structural alignments of (+)- and (-)-trans-anti-benzo[a]pyrene-dG adducts positioned at a DNA template-primer junction. , 1995, Biochemistry.

[41]  D. Jerina,et al.  Mutagenic selectivity at the HPRT locus in V-79 cells: comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,-10-epoxide enantiomers with high and low carcinogenic activity. , 1994, Carcinogenesis.

[42]  R H Sarma,et al.  Structural Biology: The State of the Art. , 1994, Journal of biomolecular structure & dynamics.

[43]  D. Jerina,et al.  Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. , 1993, Cancer research.

[44]  D. Patel,et al.  Solution conformation of the (+)-cis-anti-[BP]dG adduct in a DNA duplex: intercalation of the covalently attached benzo[a]pyrenyl ring into the helix and displacement of the modified deoxyguanosine. , 1993, Biochemistry.

[45]  T. Krugh,et al.  Structural characterization of an N-acetyl-2-aminofluorene (AAF) modified DNA oligomer by NMR, energy minimization, and molecular dynamics. , 1993, Biochemistry.

[46]  D. Patel,et al.  Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Patel,et al.  NMR structural studies of the ionizing radiation adduct 7-hydro-8-oxodeoxyguanosine (8-oxo-7H-dG) opposite deoxyadenosine in a DNA duplex. 8-Oxo-7H-dG(syn).dA(anti) alignment at lesion site. , 1991, Biochemistry.

[48]  D. Jerina,et al.  Metabolism of benzo[a]pyrene. VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides. , 1977, Chemico-biological interactions.

[49]  M. D. Topal,et al.  Complementary base pairing and the origin of substitution mutations , 1976, Nature.

[50]  S. Creighton,et al.  Gel fidelity assay measuring nucleotide misinsertion, exonucleolytic proofreading, and lesion bypass efficiencies. , 1995, Methods in enzymology.

[51]  D. Jerina,et al.  Covalent nucleoside adducts of benzo[a]pyrene 7,8-diol 9,10-epoxides: structural reinvestigation and characterization of a novel adenosine adduct on the ribose moiety , 1991 .

[52]  D. Jerina,et al.  Covalent bonding of bay-region diol epoxides to nucleic acids. , 1991, Advances in experimental medicine and biology.

[53]  D. Jerina,et al.  Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons. , 1986, Advances in experimental medicine and biology.

[54]  D. Parke,et al.  Biological Reactive Intermediates , 1977, Springer US.